How Outsourcing and Advanced Manufacturing Are Shaping Orthopedic CMOs According to a newly published market research report by 24LifeSciences, global orthopedic contract manufacturing market is valued at USD 14.5 billion in 2026 and is projected to reach USD 23.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. Orthopedic contract manufacturing involves specialized third-party production for medical device companies, offering design, development, and manufacturing services. This sector is critical for producing a wide array of essential devices, including joint reconstruction implants (for hips, knees, and shoulders), spinal devices, trauma fixation systems, and precision surgical instruments. The outsourcing model enables original equipment manufacturers (OEMs) to leverage advanced capabilities in precision machining, additive manufacturing (3D printing), and surface treatments while navigating the complex regulatory landscape governed by agencies like the FDA and EMA. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8702/orthopedic-contract-manufacturing-market

Self-Administered Medication Market’s CAGR of 6.3%: Leaders Shaping Home Care According to a newly published market research report by 24LifeSciences, global self-administered medication market was valued at USD 185.6 billion in 2026 and is projected to reach USD 285.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period. Self-administered medications encompass pharmaceutical products that patients can safely use without direct professional supervision, spanning various administration routes including oral tablets, subcutaneous injections, nasal sprays, and transdermal patches. This market represents a fundamental shift toward patient-centered healthcare, empowering individuals to manage chronic conditions like diabetes, rheumatoid arthritis, and hormone deficiencies conveniently at home. The growing acceptance of these therapies reflects broader trends in healthcare decentralization and patient autonomy. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8887/self-administered-medication-market

Top 7 Treatment Advances Transforming Thoracic Outlet Syndrome Care According to a newly published market research report by 24LifeSciences, global thoracic outlet syndrome treatment market is valued at USD 1.52 billion in 2026 and is projected to reach USD 2.27 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period. Thoracic Outlet Syndrome (TOS) is a complex clinical condition caused by the compression of neurovascular structuresthe brachial plexus, subclavian artery, and subclavian veinas they pass through the thoracic outlet, the narrow space between the collarbone and first rib. This compression manifests in three primary types: neurogenic TOS (most prevalent), venous TOS, and arterial TOS, each requiring distinct diagnostic and therapeutic strategies. The increasing clinical recognition of its varied symptomatology, from pain and numbness to vascular complications, underscores its growing significance in musculoskeletal and vascular medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9226/thoracic-outlet-syndrome-treatment-market

Pre-Pregnancy Genetic Testing Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global pre-pregnancy genetic testing market is valued at USD 1.83 billion in 2026 and is projected to reach USD 3.87 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period. Pre-pregnancy genetic testing, clinically known as carrier screening, is a vital diagnostic tool used to identify individuals or couples who carry gene mutations that could lead to serious genetic disorders in their offspring, such as cystic fibrosis, spinal muscular atrophy (SMA), and fragile X syndrome. These tests, typically performed via blood or saliva samples, provide essential information for informed family planning and reproductive decision-making. The increasing integration of advanced genomic technologies and rising awareness about hereditary conditions are fundamentally transforming preconception care worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9121/pre-pregnancy-genetic-testing-market

Global Ulnar Nerve Treatment Market Projected to Grow at a CAGR of 6.8% by 2034 According to a newly published market research report by 24LifeSciences, global ulnar nerve treatment market is valued at USD 1.52 billion in 2026 and is projected to reach USD 2.65 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. Ulnar nerve treatment encompasses a comprehensive range of therapeutic interventions aimed at addressing conditions such as ulnar neuropathy and cubital tunnel syndrome, which result from the compression or irritation of the ulnar nerve. This major peripheral nerve, extending from the neck down to the hand, is critical for motor function and sensation in the forearm and the fourth and fifth fingers. Due to its superficial location at the elbow, it is highly susceptible to injury from prolonged pressure or repetitive motion, leading to debilitating symptoms including pain, numbness, and muscle weakness, necessitating timely and effective treatment strategies. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9074/ulnar-nerve-treatment-market

What Is the Future of the Gastrointestinal Therapeutics Market? Growth Forecasts According to a newly published market research report by 24LifeSciences, global gastrointestinal therapeutics market is valued at USD 35,410 million in 2026 and is projected to reach USD 51,860 million by 2034, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period. Gastrointestinal therapeutics comprise a critical class of pharmaceuticals designed to treat a wide range of disorders affecting the digestive system, from the esophagus to the colon. This includes prevalent conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and inflammatory bowel disease (IBD). The therapeutic arsenal includes well-established drugs like proton pump inhibitors, biologics, and antacids, commercially available under brands such as Aciphex (rabeprazole) and Prilosec (omeprazole). The sustained efficacy and expanding applications of these treatments continue to underpin their importance in both primary care and specialized gastroenterology practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8881/gastrointestinal-therapeutics-market

Top 10 Companies Shaping the Global Parathyroid Disorders Market (2026–2034) According to a newly published market research report by 24LifeSciences, global parathyroid disorders market is valued at USD 2.1 billion in 2026 and is projected to reach USD 3.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Parathyroid disorders are medical conditions resulting from the dysfunction of the parathyroid glands, four small glands located in the neck that regulate the body's calcium levels. These disorders lead to abnormal calcium levels in the blood, which can cause significant health issues such as brittle bones (osteoporosis), kidney stones, chronic fatigue, and muscle weakness. The primary disorders include hyperparathyroidism (overactive glands), hypoparathyroidism (underactive glands), and the rare parathyroid cancer. Market growth is primarily driven by an aging global population more susceptible to these conditions and the rising prevalence of chronic kidney disease (CKD), a major cause of secondary hyperparathyroidism. Furthermore, advancements in diagnostic techniques, such as more sensitive parathyroid hormone (PTH) assays, are facilitating earlier and more accurate detection. Key players like Amgen, with its calcimimetic drug Cinacalcet, and Abbott Laboratories, a leader in diagnostic solutions, are actively shaping the treatment landscape through innovation and strategic initiatives, contributing to market expansion. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9574/parathyroid-disorders-market

Orphan Diseases Market to Reach USD 834 million by 2034 | Growth Trends & Insights According to a newly published market research report by 24LifeSciences, global orphan diseases market is valued at USD 315 million in 2026 and is projected to reach USD 834 million by 2034, growing at a compound annual growth rate (CAGR) of 15.3% during the forecast period. An orphan disease is officially defined as a condition affecting fewer than 200,000 people in the United States, encompassing a wide spectrum of disorders from more recognized conditions like cystic fibrosis and ALS (Lou Gehrig's disease) to rare genetic disorders such as Hutchinson-Gilford progeria syndrome. The vast majority of these diseases are genetic in origin, creating significant challenges and opportunities for targeted therapeutic development. These conditions represent some of the most complex medical challenges facing modern healthcare, requiring specialized approaches to both diagnosis and treatment. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9568/orphan-diseases-market

How Rapid and Molecular Diagnostics Are Shaping the Brucellosis Test Kits Market According to a newly published market research report by 24LifeSciences, global brucellosis test kits market is valued at USD 315.7 million in 2026 and is projected to reach USD 458.6 million by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period. Brucellosis test kits are in-vitro diagnostic (IVD) tools designed for the serological detection of antibodies against Brucella bacteria, a critical component in diagnosing both human and animal brucellosis. These kits play an essential role in managing this zoonotic disease, which causes significant economic losses in livestock production and poses serious public health risks. The most common formats include Brucella IgG, IgM, and IgA ELISA kits, along with traditional methods like rose bengal plate tests (RBPT) and advanced fluorescence polarization assays (FPA). Their accuracy and reliability make them indispensable for veterinary diagnostics, food safety programs, and human healthcare systems worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9628/brucellosis-test-kits-market

Minimally Invasive Cardiac Surgery Instruments Market’s CAGR of 6.8%: Leading Firms According to a newly published market research report by 24LifeSciences, global minimal invasive cardiac surgery instruments market is valued at USD 2.4 billion in 2026 and is projected to reach USD 4.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. Minimally invasive cardiac surgery (MICS) instruments are specialized medical devices designed to perform complex heart surgeries through small incisions, significantly reducing patient trauma compared to traditional open-heart procedures. This category includes robotic-assisted systems, thoracoscopic instruments, and direct minimally invasive tools like specialized retractors, aortic clamps, and high-definition endoscopic cameras. Their implementation enables surgeons to operate with enhanced precision through ports, leading to substantial patient benefits including shorter hospital stays, faster recovery times, reduced blood loss, and improved cosmetic outcomes. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10509/minimal-invasive-cardiac-surgery-instruments-market

Global Waldenström’s Macroglobulinemia Treatment Market to Grow at a CAGR of 7.2% According to a newly published market research report by 24LifeSciences, global Waldenstrom's Macroglobulinemia treatment market is valued at USD 1.5 billion in 2026 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period. Waldenstroms Macroglobulinemia (WM), a rare and indolent type of non-Hodgkin lymphoma, is characterized by the overproduction of immunoglobulin M (IgM) monoclonal protein. It represents a significant clinical challenge due to its chronic nature and the complexity of symptom management. While not curable, the disease is highly treatable, with therapeutic strategies evolving rapidly. The current treatment landscape encompasses chemotherapy regimens (such as bendamustine combined with rituximab), monoclonal antibodies, and most notably, Brutons Tyrosine Kinase (BTK) inhibitors. These treatment classes aim to control disease progression, manage symptoms like hyperviscosity syndrome and cytopenias, and significantly improve both progression-free survival and overall quality of life for patients. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10333/waldenstroms-macroglobulinemia-treatment-market

What Is the Future of the Fully Automated Blood Coagulation Analyzers Market? According to a newly published market research report by 24LifeSciences, global fully automated blood coagulation analyzers market is valued at USD 2.5 billion in 2026 and is projected to reach USD 4.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period. Fully automated blood coagulation analyzers are critical diagnostic instruments used to assess the blood's ability to clot, measuring essential hemostasis parameters like Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), Thrombin Time (TT), and Fibrinogen concentration. These systems enhance laboratory efficiency by minimizing tedious manual interventions associated with sample and reagent handling while significantly improving the accuracy and reproducibility of results. Their ability to consolidate a wide range of analytical functions onto a single unit saves valuable laboratory space and simplifies instrument management, making them indispensable in modern clinical diagnostics. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10474/fully-automated-blood-coagulation-analyzers-market